HepQuant

HepQuant provides minimally invasive diagnostic tests to quantify liver health and enable liver specialists to more effectively manage liver disease.

[HepQuant @HepQuant]

https://t.co/hGVLKndONs

[HepQuant @HepQuant]

HepQuant is seeking a dynamic individual to join our team!

https://t.co/tXSmG8zdom

[HepQuant @HepQuant]

HepQuant to Present at Key Liver Conferences to Highlight Applications of HepQuant DuO™. https://t.co/BB8ujlWDSV

[HepQuant @HepQuant]

HepQuant is excited to present 8 new abstracts at the upcoming Liver Conferences! Please join us March 18-21 at the Global Hepatis Summit 2025 and March 20-22 at the 5th Annual Liver Connect Conference. We look forward to connecting with you! https://t.co/frfIP4OJjI

[HepQuant @HepQuant]

Very pleased to announce that medical diagnostics industry veteran Kelly R. Pitts, Ph.D., is our new Chief Operating Officer! https://t.co/nKeaJgKk8E

[HepQuant @HepQuant]

New Year, New Digs! https://t.co/zkK8vO6Htz

[HepQuant @HepQuant]

Networking, education and collaboration were all part of the mix in the 2022 rendition of the Rocky Mountain Life Science Investor and Partnering Conference hosted by the Colorado BioScience Association. #liverhealth, #liverfunctiontest, #clinicaltrials

[HepQuant @HepQuant]

Proud to sponsor #CLM22! Looking forward to exchanging ideas and collaborating!

[HepQuant @HepQuant]

An important milestone: Our HepQuant laboratory has achieved COLA accreditation for laboratory quality assurance. https://t.co/nQhUIpys5g

[Hep Magazine @hepatitismag]

#HepBasics Everything that starts in the mouth passes through the #liver, including prescription, over-the-counter (OTC) and recreational drugs. https://t.co/Twur9hPqzT

[HepQuant @HepQuant]

Good info on the Liver Basics https://t.co/broapcE1T3 via @hepatitismag

[HepQuant @HepQuant]

Quote-worthy: ���Take care of your liver, and it will take care of you.” https://t.co/fkXYiU9WBf #liverhealth #liverdisease #MedTech #Healthcare

[HepQuant @HepQuant]

Preliminary data from the HepQuant SHUNT-V Pivotal study released during the 72nd AASLD Annual Meeting and and AHA 2021 Annual Meeting. https://t.co/ZngVmxFEUf #LiverMTG21 #liverdisease #MedTech #Healthcare #TLMdX

[AASLD President @AASLDPresident]

Who else is excited for Day 3 of #TLMdX? The first two days have been excellent…and there’s still so much to come! Join us today for the Presidential Plenary: Clinical and Translational, engaging, and innovative sessions, research workshops, fun social events, and more.

[AASLD President @AASLDPresident]

Due to recent developments surrounding the virus and its variants, significant concerns have been raised about safely hosting The Liver Meeting in Anaheim. As a result, this year’s meeting will be held virtually.

Governing Board's full statement here: https://t.co/C0lZdjZEGh

[Hep Magazine @hepatitismag]

Most People With Cirrhosis Don't Receive Recommended Monitoring https://t.co/sKSzaV7yOY #fattyliver #hepatitisB #hepatitisC

[HepQuant @HepQuant]

HepQuant and @PerspectumGroup are combining their function and imaging modalities for more comprehensive liver health assessments in clinical trials through a new business collaboration: https://t.co/4PBdg02SXY
#liverdisease #livercancer #NASH #NAFLD #MedTech #Healthcare

[HepQuant @HepQuant]

On international women’s day - a shout out to some superb women leading the way at HepQuant! We also want to encourage women of all ages to pursue their passions in the field of science and medicine. #InternationalWomensDay

[HepQuant @HepQuant]

Our recent publication in AP&T examines the SHUNT test results relative to the risk of liver decompensation in cirrhotic patients when their disease severity index (DSI) is ≥ 24 or greater. Read more: https://t.co/yB589l15Ay #livercirhossis #healthcare #medtech #liverdisease

[HepQuant @HepQuant]

5 ways you can celebrate Black History Month virtually

The 2021 version of Black History Month may look and feel a lot different this year amid the coronavirus pandemic but CNN offers some ideas on celebrating.

https://t.co/EF2TlN9Gjq